Amaze Pharmaceuticals Limited, a active public limited company, was established on 21 October 2008 in Hyderabad, Telangana, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24233TG2008PLC061494. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
It upholds a compliant status. Its leadership includes Mattaparti Keshavarjuni Devi (Director), Vejju Venkateswara Rao (Director), Alapati Purushottam (Director). Past directors included Srinivasu Kurella, Mattaparti Prabhakar Rao, Alapati Purushottam. It holds no open charges and ₹2.12 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Flat No-404, Akash Deep Apartments, 1-10-125/4/F Mayuri Marg, Begumpet, Hyderabad, Telangana, 500016.
U24233TG2008PLC061494
061494
21 October 2008
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Amaze Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mattaparti Keshavarjuni Devi | Director | 21 Oct 2008 | Current |
| Vejju Venkateswara Rao | Director | 30 Sep 2020 | Current |
| Alapati Purushottam | Director | 23 Aug 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Aug 2013 | Past |
| Pramod Abcsdd | Managing Director | 30 Sep 2020 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Amaze Pharmaceuticals Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 154.88% increase. The company also saw a substantial improvement in profitability, with a 147.36% increase in profit. The company's net worth Soared by an impressive increase of 10.36%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Amaze Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,115,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Aug 2015 | State Bank Of India | ₹0.92 M | Satisfied |
| 20 Sep 2014 | State Bank Of India | ₹1.20 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Amaze Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Amaze Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Amaze Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Amaze Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Amaze Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was recorded as a recent event.
A charge registered on 10 Aug 2015 via Charge ID 10590249 with State Bank Of India was fully satisfied on 24 Mar 2021. was recorded as a recent event.
Vejju Venkateswara Rao was appointed as a Director was appointed as a Director on 30 Sep 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Progress on A charge registered on 20 Sep 2014 via Charge ID 10525368 with State Bank Of India was fully satisfied on 18 Oct 2016. was documented.
The activity A charge with State Bank Of India amounted to Rs. 0.92 M with Charge ID 10590249 was registered on 10 Aug 2015. was completed.
The CIN of Amaze Pharmaceuticals Limited is U24233TG2008PLC061494.
Amaze Pharmaceuticals Limited is headquartered at Flat No-404, Akash Deep Apartments, 1-10-125/4/F Mayuri Marg, Begumpet, Hyderabad, Telangana, 500016.
Amaze Pharmaceuticals Limited was incorporated on 21 October 2008.
The current directors of Amaze Pharmaceuticals Limited are
The primary industry of Amaze Pharmaceuticals Limited is Manufacturing.
Amaze Pharmaceuticals Limited is unlisted.
The authorized capital of Amaze Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of Amaze Pharmaceuticals Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX